PRVA vs. GH, OPCH, RDNT, BTSG, SHC, SGRY, VCYT, LFST, CON, and TDOC
Should you be buying Privia Health Group stock or one of its competitors? The main competitors of Privia Health Group include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Veracyte (VCYT), LifeStance Health Group (LFST), Concentra Group Holdings Parent (CON), and Teladoc Health (TDOC). These companies are all part of the "healthcare" industry.
Privia Health Group vs.
Guardant Health (NASDAQ:GH) and Privia Health Group (NASDAQ:PRVA) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership.
92.6% of Guardant Health shares are held by institutional investors. Comparatively, 94.5% of Privia Health Group shares are held by institutional investors. 5.5% of Guardant Health shares are held by insiders. Comparatively, 14.2% of Privia Health Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Guardant Health has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500. Comparatively, Privia Health Group has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500.
Guardant Health presently has a consensus price target of $44.39, suggesting a potential upside of 3.77%. Privia Health Group has a consensus price target of $24.94, suggesting a potential upside of 1.24%. Given Guardant Health's higher possible upside, equities research analysts clearly believe Guardant Health is more favorable than Privia Health Group.
In the previous week, Guardant Health had 5 more articles in the media than Privia Health Group. MarketBeat recorded 14 mentions for Guardant Health and 9 mentions for Privia Health Group. Guardant Health's average media sentiment score of 0.54 beat Privia Health Group's score of 0.38 indicating that Guardant Health is being referred to more favorably in the media.
Privia Health Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.
Privia Health Group has a net margin of 0.75% compared to Guardant Health's net margin of -74.02%. Privia Health Group's return on equity of 2.02% beat Guardant Health's return on equity.
Guardant Health received 220 more outperform votes than Privia Health Group when rated by MarketBeat users. However, 75.56% of users gave Privia Health Group an outperform vote while only 70.59% of users gave Guardant Health an outperform vote.
Summary
Privia Health Group beats Guardant Health on 11 of the 18 factors compared between the two stocks.
Get Privia Health Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Privia Health Group Competitors List
Related Companies and Tools
This page (NASDAQ:PRVA) was last updated on 2/21/2025 by MarketBeat.com Staff
